Status:

WITHDRAWN

Vaginal Progesterone in Twins With Short Cervix

Lead Sponsor:

Obstetrix Medical Group

Conditions:

Premature Birth

Eligibility:

FEMALE

18-60 years

Phase:

PHASE2

PHASE3

Brief Summary

A Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial of Vaginal Progesterone to Prevent Early Preterm Birth In Twin Pregnancy with Short Cervix.

Detailed Description

This is a placebo-controlled, double-blind, randomized clinical trial of asymptomatic women with twin pregnancy and a cervix length 10 mm to 25 mm discovered on a routine screening transvaginal sonogr...

Eligibility Criteria

Inclusion

  • Gestational age between 20w0d and 24w0d
  • Twin pregnancy, diamniotic-dichorionic, both twins living
  • Cervical length 10 mm to 25 mm discovered by a screening transvaginal ultrasound exam

Exclusion

  • Mother less than 18 years of age
  • Uterine contractions of 40 seconds duration or more, 10 or more per hour
  • Rupture of fetal membranes (leakage of amniotic fluid one or both sacs)
  • Ongoing vaginal bleeding
  • Any condition likely to cause serious neonatal morbidity independent of gestational age, including:
  • fetal malformation likely to require surgery
  • fetal malformation involving vital organs
  • fetal viral infection
  • hydrops fetalis
  • discordance in estimated fetal weight more than 10%
  • velamentous insertion of umbilical cord of either twin
  • placenta previa of either placenta
  • Any contraindication to continuing the pregnancy
  • Cervical cerclage in place or planned
  • Any contraindication to vaginal micronized progesterone, including:
  • Known sensitivity to progesterone or any of the other ingredients
  • Liver dysfunction or disease
  • Known or suspected malignancy of breast or genital organs
  • Active thromboembolic disorder, or history of hormone-associated thromboembolic disorder

Key Trial Info

Start Date :

March 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2018

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01812239

Start Date

March 1 2014

End Date

August 1 2018

Last Update

December 19 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Good Samaritan Hospital

San Jose, California, United States, 95008